Molecular Network Approach Reveals As a Central Target of Cardiac ProtectomiRs
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Cardioprotective medications are still unmet clinical needs. We have previously identified several cardioprotective microRNAs (termed ProtectomiRs), the mRNA targets of which may reveal new drug targets for cardioprotection. Here we aimed to identify key molecular targets of ProtectomiRs and confirm their association with cardioprotection in a translational pig model of acute myocardial infarction (AMI). By using a network theoretical approach, we identified 882 potential target genes of 18 previously identified protectomiRs. The gene was the most central and it was ranked first in the protectomiR-target mRNA molecular network with the highest node degree of 5. Therefore, and its targeting microRNAs were further validated in heart samples obtained from a translational pig model of AMI and cardioprotection induced by pre- or postconditioning. Three out of five -targeting pig homologue of rat ProtectomiRs showed significant upregulation in postconditioned but not in preconditioned pig hearts. was downregulated at the mRNA and protein level in ischemic postconditioning but not in ischemic preconditioning. This is the first demonstration that is the central molecular target of ProtectomiRs and that decreased expression may regulate ischemic postconditioning-, but not preconditioning-induced acute cardioprotection. We conclude that is a potential novel drug target for acute cardioprotection.
MINOCA: A Pathophysiological Approach of Diagnosis and Treatment-A Narrative Review.
Khattab E, Karelas D, Pallas T, Kostakis P, Papadopoulos C, Sideris S Biomedicines. 2024; 12(11).
PMID: 39595023 PMC: 11592352. DOI: 10.3390/biomedicines12112457.
Whole-genome sequencing reveals genetic structure and adaptive genes in Nepalese buffalo breeds.
Dhakal A, Si J, Sapkota S, Pauciullo A, Han J, Gorkhali N BMC Genomics. 2024; 25(1):1082.
PMID: 39543523 PMC: 11566569. DOI: 10.1186/s12864-024-10993-w.
Szabados T, Molnar A, Kenyeres E, Gomori K, Pipis J, Posa B Antioxidants (Basel). 2024; 13(6).
PMID: 38929113 PMC: 11201193. DOI: 10.3390/antiox13060674.
YB-1 Is a Novel Target for the Inhibition of α-Adrenergic-Induced Hypertrophy.
Heger J, Partsch S, Harjung C, Varga Z, Baranyai T, Weiss J Int J Mol Sci. 2024; 25(1).
PMID: 38203580 PMC: 10778708. DOI: 10.3390/ijms25010401.
Ruppert M, Korkmaz-Icoz S, Benczik B, Agg B, Nagy D, Balint T Sci Rep. 2023; 13(1):16122.
PMID: 37752166 PMC: 10522609. DOI: 10.1038/s41598-023-43171-1.